About Taizhou Hospital of Zhejiang Province
Clinical Trials at Taizhou Hospital of Zhejiang Province
During the past decade, Taizhou Hospital of Zhejiang Province conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on
average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Taizhou Hospital of Zhejiang Province" #1 sponsor was "Janssen Research & Development, LLC" with 3 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Pfizer" with 2 trials sponsored, "YiYang Zhu" with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Taizhou Hospital of Zhejiang Province"
#1 collaborator was "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator and "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Taizhou Hospital of Zhejiang Province
According to Clinical.Site data, the most researched conditions in "Taizhou Hospital of Zhejiang Province" are
"Carcinoma, Non-Small-Cell Lung" (3 trials), "Chronic Heart Failure" (1 trials), "Complicated Intra-abdominal Infection" (1 trials), "Gastric Cancer" (1 trials) and "Hepatitis B" (1 trials). Many other conditions were trialed in "Taizhou Hospital of Zhejiang Province" in a lesser frequency.
Clinical Trials Intervention Types at Taizhou Hospital of Zhejiang Province
Most popular intervention types in "Taizhou Hospital of Zhejiang Province" are "Drug" (11 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Amivantamab" (3 trials), "Carboplatin" (2 trials), "Lazertinib" (2 trials), "Pemetrexed" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Taizhou Hospital of Zhejiang Province
The vast majority of trials in "Taizhou Hospital of Zhejiang Province" are
11 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Taizhou Hospital of Zhejiang Province
Currently, there are NaN active trials in "Taizhou Hospital of Zhejiang Province".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Taizhou Hospital of Zhejiang Province,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Taizhou Hospital of Zhejiang Province, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".